Mobile

Safety and Efficacy Study of Brodalumab in Subjects with Inadequately Controlled Asthma and High Reversibility

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-003351-11

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the efficacy of brodalumab compared with placebo as measured by the change in asthma control (based on the Asthma Control Questionnaire [ACQ]) from baseline at week 24 in subjects with inadequately controlled asthma and high reversibility despite standard of care.

Critère d'inclusion

  • Asthma

Liens